GenX faces a higher risk of 17 cancer types than older generation
Seventeen types of cancer are common in US millennials and the incidence rate for some forms is two to three times higher in.
Drugs
Health
Pharma
Drugs
Health
Pharma
FDA nod for Gilead to expand hepatitis drug to six years or older patients
HQ Team March 28, 2024: US regulator, the FDA has approved Gilead Sciences, Inc.’s supplemental new drug application for treating chronic hepatitis B.
Drugs
Health
Pharma
Bristol Myers says liver cancer therapy trial improves overall survival rate
HQ Team March 20, 2024: Bristol Myers Squibb, a New Jersey-based drugmaker, announced it has met its primary goal of improved overall survival.
Drugs
Health
Pharma
Roche’s under-the-skin cancer injection gets Britain’s nod
HQ Team August 30, 2023: Roche’s atezolizumab drug Tecentriq, to treat cancer, was approved by Britain’s Medicines and Healthcare Products Regulatory Agency. Tecentriq.
Drugs
Health
Pharma
Delcath Systems gets FDA nod for Hepzato Kit to treat uveal melanoma
HQ Team August 16, 2023: Delcath Systems Inc., has been granted an FDA nod for its Hepzato Kit, a liver-directed treatment for patients.
Drugs
Health
Pharma
Hepatitis C virus uses a molecular mask to escape immune systems: Dutch research
HQ Team July 6, 2023: The Hepatitis C virus wears a “mask” and remains hidden to evade the human immune system to cause.
Health
Uncategorized
Liver cancer deaths may increase by 55% in another 20 years
Liver cancer deaths set to increase by 50 percent by 2040; study